Leading Innovation in the Life Sciences
New York Bio Connect aims to simplify and amplify the state and city’s life sciences ecosystem, organizing opportunities from Manhattan to Buffalo to position students, entrepreneurs, investors, policy makers, and established industry leaders for success.
Funding
Investing in innovation
Careers
Your future starts here
The Latest
Buffalo Biotech Startups Pitch at NewYorkBIO Mini Pitch Day as the Region’s Innovation Scene Heats Up
Entrepreneurial momentum has been hard to miss this fall. Springboard’s Entrepreneurial Huddle aligned with the Buffalo Bills’ home opener, turning game day into a gathering point for the region supporters and founders. Luminate NY in Rochester awarded a combined $2 million dollars to its ninth cohort of photonics companies at the intersection of optics, health […]
Building What’s Next For the Life Sciences: Self-Paced Online Micro-Credentials
Shaping treatments and improving patient lives means constantly learning and adapting. With Tufts University’s online life sciences micro-credentials, you’ll build in-demand skills and earn credentials that reflect your growing expertise. Areas of focus include: ● Communicating scientific information clearly and effectively ● Leading & managing complex projects ● Navigating emerging technologies & workplace change ●…
NewYorkBIO Holiday Reception @ NYSE
NewYorkBIO’s Holiday Reception is an annual networking event at the iconic New York Stock Exchange building at the heart of New York’s Financial District bringing together members, emerging biotech and life sciences companies developing novel therapeutics with New York’s financial, venture capital, and institutional investment communities.
Opinion: Data center legislation could inadvertently hurt biomedical research
Bristol Myers Squibb bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod
The FDA granted accelerated approval on Aug. 13 to Bristol Myers Squibb’s Zenbexus (iberdomide), used with Darzalex and dexamethasone, for adults with multiple myeloma who have had at least one prior line of therapy. It is the first approval in the CELMoD class — oral agents that recruit the cell’s own disposal machinery to degrade…
LIFE SCIENCES IN NEW YORK
Where science and opportunity come together
New York’s life science sector has attracted unprecedented investment, expanded research clusters across the state, and nurtured the growth of early-stage companies.
#2
NATIONAL R&D SPEND
100,000+
LIFE SCIENCES JOBS
25%
CLINICAL TRIALS IN THE U.S.